Publications

Src and Abl as Therapeutic Targets in Lung Cancer: Opportunities for Drug Repurposing

AuthID
P-01A-41J

Author(s)

Ramos, R

Sousa, C

Vale, N

Document Type

Review

Year published

2025

Published

in PHARMACEUTICALS, ISSN: 1424-8247

Volume: 18, Issue: 10, Pages: 1426 (20)

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Unpaywall^®

Google Scholar^®

Publication Identifiers

DOI: 10.3390/ph18101426

Pubmed: 41155542

Scopus: 2-s2.0-105020158228

Unpaywall: 10.3390/ph18101426

Wos: WOS:001601529600001

Source Identifiers

ISSN: 1424-8247

Export Publication Metadata

Marked List

Add to Marked List

Citations

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference

No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text

Full Text @ sfx.b-on.pt

Src and Abl as Therapeutic Targets in Lung Cancer: Opportunities for Drug Repurposing

Useful Links

Get Help

Federated Authentication (Click on the image)

Src and Abl as Therapeutic Targets in Lung Cancer: Opportunities for Drug Repurposing

Useful Links

Get Help